Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Indoleamine 2,3-dioxygenase (IDO) is induced by proinflammatory cytokines and by CTLA-4-expressing T cells and constitutes an important mediator of peripheral immune tolerance. In chronic hepatitis C, we found upregulation of IDO expression in the liver and an increased serum kynurenine/tryptophan r...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Larrea, E, Riezu-Boj, J, Gil-Guerrero, L, Casares, N, Aldabe, R, Sarobe, P, Civeira, M, Heeney, J, Rollier, C, Verstrepen, B, Wakita, T, Borrás-Cuesta, F, Lasarte, J, Prieto, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2007

Míreanna comhchosúla

Indoleamine 2,3-dioxygenase in endometriosis
de réir: Hui-Li Yang, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
de réir: Lieve Brochez, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
de réir: Mona F.M El-Karn, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
de réir: Röhrig, U, et al.
Foilsithe / Cruthaithe: (2010)

Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration.
de réir: Chun-Sing Lam, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
de réir: Aleksandar Acovic, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
de réir: Andrew L. Mellor, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1
de réir: Asha M. Rudjord-Levann, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
de réir: Quan, J, et al.
Foilsithe / Cruthaithe: (2008)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
de réir: Quan, J, et al.
Foilsithe / Cruthaithe: (2008)

Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.
de réir: Kudo, Y, et al.
Foilsithe / Cruthaithe: (2004)

Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia.
de réir: Kudo, Y, et al.
Foilsithe / Cruthaithe: (2003)

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
de réir: Orabona, C, et al.
Foilsithe / Cruthaithe: (2018)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
de réir: Chiara Suvieri, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Research progress of indoleamine 2,3-dioxygenase 1 in gastric cancer
de réir: Pei Xiaxia, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
de réir: Camilla Grønkjær Jensen, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
de réir: Asim Farooq, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Comprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
de réir: Nao Hirata, et al.
Foilsithe / Cruthaithe: (2018-09-01)

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
de réir: Yuhei Shibata, et al.
Foilsithe / Cruthaithe: (2016-01-01)

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
de réir: Ding Ya, et al.
Foilsithe / Cruthaithe: (2009-08-01)

Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
de réir: Tao Zhang, et al.
Foilsithe / Cruthaithe: (2017-01-01)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
de réir: Lilla Hornyák, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
de réir: Corina Bello, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy
de réir: Ning Deng, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Highly Efficient Stable Expression of Indoleamine 2,3 Dioxygenase Gene in Primary Fibroblasts
de réir: Rezakhanlou Alireza, et al.
Foilsithe / Cruthaithe: (2010-03-01)

IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression
de réir: Hanako Ohmatsu, et al.
Foilsithe / Cruthaithe: (2017-02-01)

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
de réir: Christiane A Opitz, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Indoleamine 2,3 dioxygenase activity aggravates the course and pathology of murine tuberculosis
de réir: Guo, L, et al.
Foilsithe / Cruthaithe: (2018)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
de réir: V. A. Kozlov, et al.
Foilsithe / Cruthaithe: (2017-07-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
de réir: Cemil Bilir, M.D., et al.
Foilsithe / Cruthaithe: (2017-07-01)

Serum indoleamine 2,3-dioxygenase level and diagnostic value in patients with rosacea
de réir: Merve Sena Odabasi, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.
de réir: Shamaila Munir, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer
de réir: Anshuman Panda, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries
de réir: Lingyan Xu, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Tolerance induction by monoclonal CD3 antibodies is dependent on indoleamine 2,3 dioxygenase (IDO)
de réir: Kuhn, C, et al.
Foilsithe / Cruthaithe: (2012)

Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
de réir: Weirui Li, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Modulation of indoleamine 2,3-dioxygenase by interferon-gamma in human placental chorionic villi.
de réir: Kudo, Y, et al.
Foilsithe / Cruthaithe: (2000)

Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.
de réir: Kudo, Y, et al.
Foilsithe / Cruthaithe: (2001)

Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma
de réir: Heike Loeser, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Correlation of Indoleamine-2,3-Dioxygenase and Chronic Kidney Disease: A Pilot Study
de réir: Binbin Pan, et al.
Foilsithe / Cruthaithe: (2021-01-01)